TY - JOUR T1 - Qualitative and quantitative evaluation of the marketing Passiflora incarnata L. formulations in Turkey AU - Çevik, Dicle AU - Güzelmeriç, Etil AU - Yeşilada, Erdem PY - 2025 DA - June JF - Journal of Research in Pharmacy JO - J. Res. Pharm. PB - Marmara University WT - DergiPark SN - 2630-6344 SP - 609 EP - 619 VL - 27 IS - 2 LA - en AB - assiflora incarnata L. (Passifloraceae) has been traditionally used to treat ailments such as dysmenorrhoea,insomnia, epilepsy and neuralgia. In this study, qualitative and quantitative analyses of P. incarnata products in theTurkish market were studied via High-Performance Thin-Layer Chromatography (HPTLC) and High-PerformanceLiquid Chromatography (HPLC) and vitexin, isovitexin, orientin and isoorientin were used as bioactive markercompounds. Seven herbal tea samples (T1-7) composing P. incarnata herb, eighteen capsules/tablets/powders (C1-18)and four syrups (S1-4) containing P. incarnata extract were purchased from pharmacies, markets, herbalists or e-commerce websites in Turkey. Comparing HPTLC fingerprinting profiles of the reference plant (P. incarnata) with thesamples indicated that only T1, C1-C3, C5, C7, C11, C12, C14, C15 and S1 showed similar chemical fingerprints withthe reference plant material. On the HPLC analysis, the total ratio of investigated compounds was 6.33% and 2.08% inhydroalcoholic (70% EtOH) and aqueous extracts of reference P. incarnata, respectively. Furthermore, hydroalcoholicextract of T1 was found to possess higher content (6.40%) than other tested tea samples (T2-6). However, based on themorphological characteristics, the tea sample (T7) was identified as Jerusalem thorn (Paliurus spina-christi) fruits. Amongthe food supplements (C1-18), only nine were determined to contain the reference molecules (3.301-0.827%), consistentwith HPTLC results, and C1 exerted the highest total percentage. To conclude, most of the marketing P. incarnataproducts in Turkey were adulterated or contained lower amounts of bioactive components. KW - Passiflora incarnata KW - Passifloraceae KW - High-Performance Thin-Layer Chromatography KW - High-Performance Liquid Chromatography KW - Quality control CR - Qiu J, Shen B, Zhao M, Wang Z, Xie B, Xu Y.A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: Implications and policy recommendations. Gen Psychiatry. 2020; 33: 19–21. https://doi.org/10.1136/gpsych-2020-100213 CR - Chanda S. Importance of pharmacognostic study of medicinal plants: An overview. J Pharmacogn Phytochem. 2014; 2: 69–73. CR - Calahan J, Howard D, Almalki AJ, et al. Chemical Adulterants in Herbal Medicinal Products: A Review. Planta Med. 2016; 82: 505–515. https://doi.org/10.1055/s-0042-103495 CR - Deconinck E, De Leersnijder C, Custers D, Courselle P, De Beer JO. A strategy for the identification of plants in illegal pharmaceutical preparations and food supplements using chromatographic fingerprints. Anal Bioanal Chem. 2013; 405: 2341–2352. https://doi.org/10.1007/s00216-012-6649-4 CR - Dişli M, Yeşilada E. Türkiye ‘de Bitkisel Tıbbi Ürünler (Türkiye’de Bitkisel Ürünlerin Standardizasyonu, Üretimi Ve Tağşiş) : Derleme. J Biotechnol Strateg Heal Res. 2019; 3: 13–21. https://doi.org/10.34084/bshr.545498 CR - Güzelmeriç E, Çevik D, Yeşilada E. Quality assessment of marketed food supplements and herbal tea products of olive leaf in Turkey. J Res Pharm. 2020; 24: 159–169. https://doi.org/10.35333/jrp.2020.123 CR - Güzelmeriç E, Çelik C, Şen NB, Oçkun MA, Yeşilada E. Quali/quantitative research on herbal supplements containing black elder (Sambucus nigra L.) fruits. J Res Pharm. 2021; 25: 238–248. https://doi.org/10.29228/jrp.14 CR - Ulmer T, John Mochrie M. Passiflora : Passionflowers of the world, Timber Press, Portland 2004. Miroddi M, Calapai G, Navarra M, Minciullo PL, Gangemi S. Passiflora incarnata L.: Ethnopharmacology, clinical application, safety and evaluation of clinical trials. J Ethnopharmacol. 2013; 150: 791–804. https://doi.org/10.1016/j.jep.2013.09.047 CR - Dhawan K, Dhawan S, Sharma A. Passiflora: A review update. J Ethnopharmacol. 2004; 94: 1–23. https://doi.org/10.1016/j.jep.2004.02.023 CR - Taylor L, Herbal Secrets of the Rainforest, Prime Publishing Inc, Austin, TX, 1996. Committee for Herbal Medicinal Products (HMPC) Assessment Report on Passiflora incarnata L. https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-passiflora-incarnata-l- herba_en.pdf (accessed on 11 September 2022). CR - European Scientific Cooperative on Phytotherapy E.S.C.O.P. Monographs, second ed., Thieme, New York, 2003, pp. 539–546. CR - Barnes J, Anderson LA, Phillipson JD, Herbal medicines, third ed., Pharmaceutical press, 2007. Avula B, Wang YH, Rumalla CS, Smillie TJ, Khan IA. Simultaneous determination of alkaloids and flavonoids from aerial parts of Passiflora species and dietary supplements using UPLC-UV-MS and HPTLC. Nat Prod Commun. 2012; 7: 1177–1180. https://doi.org/10.1177/1934578x1200700918 CR - Speroni E, Minghetti A. Neuropharmacological activity of extracts from Passiflora incarnata. Planta Med. 1988; 54: 488–491. https://doi.org/10.1055/s-2006-962525 CR - Dhawan K, Kumar S, Sharma A. Anti-anxiety studies on extracts of Passiflora incarnata Linneaus. J Ethnopharmacol. 2001; 78: 165–170. https://doi.org/10.1016/S0378-8741(01)00339-7 CR - Dhawan K, Kumar S, Sharma A. Comparative anxiolytic activity profile of various preparations of Passiflora incarnata Linneaus. J Altern Complemantary Med. 2002; 8: 283–291. https://doi.org/10.1089/10755530260127970 CR - Dhawan K. Drug/substance reversal effects of a novel tri-substituted benzoflavone moiety (BZF) isolated from Passiflora incarnata Linn. - A brief perspective. Addict Biol. 2003; 8: 379–386. https://doi.org/10.1080/13556210310001646385 CR - Dhawan K, Kumar S, Sharma A. Evaluation of central nervous system effects of Passiflora incarnata in experimental animals. Pharm Biol 2003; 41: 87–91. https://doi.org/10.1076/phbi.41.2.87.14241 CR - Nassiri-Asl M, Shariati-Rad S, Zamansoltani F. Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: Involvement of benzodiazepine and opioid receptors. BMC Complement Altern Med. 2007; 7: 3–8. https://doi.org/10.1186/1472-6882-7-26 CR - Grundmann O, Wähling C, Staiger C, Butterweck V. Anxiolytic effects of a passion flower (Passiflora incarnata L.) extract in the elevated plus maze in mice. Pharmazie. 2009; 64: 63–64. https://doi.org/10.1691/ph.2008.8753 CR - Jawna-zboi K, Blecharz-klin K, Joniec-maciejak I, Wawer A, Pyrzanowska J, Piechal A, Mirowska-guzel D. Passiflora incarnata L . improves spatial memory, reduces stress and affects neurotransmission in rats. Phytother Res. 2016; 30 (5): 781–789. https://doi.org/10.1002/ptr.5578 CR - Kim G, Lim K, Sung H, Lee J, Kim Y, Park S. Improvement in neurogenesis and memory function by administration of Passiflora incarnata L . extract applied to sleep disorder in rodent models. J Chem Neuroanat. 2019; 98: 27–40. https://doi.org/10.1016/j.jchemneu.2019.03.005 CR - Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M. Passionflower in the treatment of generalized anxiety: A pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001; 26: 363–367. https://doi.org/10.1046/j.1365-2710.2001.00367.x CR - Movafegh A, Alizadeh R, Hajimohamadi F, Esfehani F, Nejatfar M. Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients: A double-blind, placebo-controlled study. Anesth Analg 2008; 106: 1728– 1732. https://doi.org/10.1213/ane.0b013e318172c3f9 CR - Ngan A, Conduit R. A double‐blind, placebo‐controlled investigation of the effects of Passiflora incarnata (Passion flower) herbal tea on Subjective Sleep Quality. Phytother Res., 2011; 25(8): 1153–1159. https://doi.org/10.1002/ptr.3400 CR - Aslanargun P, Cuvas O, Dikmen B, Aslan E, Yuksel MU. Passiflora incarnata Linneaus as an anxiolytic before spinal anesthesia. J Anesth. 2012; 26: 39–44. https://doi.org/10.1007/s00540-011-1265-6 CR - Janda K, Wojtkowska K, Jakubczyk K, Antoniewicz J, Skonieczna-Żydecka K. Passiflora incarnata in neuropsychiatric disorders-A systematic review. Nutrients. 2020; 12(12): 3894. https://doi.org/10.3390/nu12123894 CR - Alves JSF, Marques JI, Demarque DP, Costa LRF, Amaral JG, Lopes NP, Silva-Júnior AA, Soares LAL, Gavioli EC, Ferreira LDS, Zucolotto SM. Correction to: Involvement of isoorientin in the antidepressant bioactivity of a flavonoid- rich extract from Passiflora edulis f. flavicarpa leaves. Rev Bras Farmacogn. 2020; 30: 319. https://doi.org/10.1007/s43450-020-00051-3 CR - He M, Min J-W, Kong W-L, He X-H, Li J-X, Peng B-W. A review on the pharmacological effects of vitexin and isovitexin. Fitoterapia. 2016; 115: 74–85. https://doi.org/10.1016/j.fitote.2016.09.011 CR - Pereira CAM, Yariwake JH, Lanças FM, Wauters J-N, Tits M, Angenot L. A HPTLC densitometric determination of flavonoids from Passiflora alata, P. edulis, P. incarnata and P. caerulea and comparison with HPLC Method. Phytochem Anal. 2004; 15: 241–248. https://doi.org/10.1002/pca.778 CR - Menghini A, Mancini LA. TLC determination of flavonoid accumulation in clonal populations of Passiflora incarnata L. Pharmacol Res Commun. 1988; 20: 113–116. https://doi.org/10.1016/S0031-6989(88)80854-3 CR - Masteikova R, Bernatoniene J, Bernatoniene R, Velziene S. Antiradical activities of the extract of Passiflora incarnata. Acta Pol Pharm - Drug Res. 2008; 65: 577–583. CR - ICH Harmonised Tripartite Guideline Validation of Analytical Procedures: Text and Methodology Q2 (R1). https://database.ich.org/sites/default/files/Q2%28R1%29%20Guideline.pdf (accessed on 11 September 2022). CR - Köse EC, Köroğlu A. Passiflora genus, its importance of pharmacy and investıigation of the samples which is sold by passiflora (çarkıfelek) name in the market of Turkey. Biol Divers Conserv. 2021; 14: 138–145. https://doi.org/10.46309/biodicon.2021.814383 CR - European Pharmacopoeia (Ph. Eur.), seventh ed., Council of Europe, Strasbourg, France, 2010. Kırmızıbekmez H, Demir D. Iridoid glycosides and phenolic compounds from the flowers of Vitex agnus-castus. Helv Chim Acta. 2016; 99: 518–522. https://doi.org/10.1002/hlca.201600022 UR - https://dergipark.org.tr/en/pub/jrespharm/issue//1690859 L1 - https://dergipark.org.tr/en/download/article-file/4834574 ER -